使用基于器官的管电流调制时评估胸部CT中甲状腺和乳腺的患者特异性剂量及总体风险
这项回顾性研究(2015年1月至2016年12月)通过蒙特卡洛模拟计算50例女性患者胸部CT的患者特异性剂量分布,评估基于器官的管电流调制(OBTCM)对甲状腺和乳腺的潜在剂量降低。结果显示甲状腺剂量降低18%、乳腺降低9%,但肺、肝、肾剂量分别升高17%、11%、26%;癌症发病的终生归因风险(LAR)在常规扫描与OBTCM间无显著差异(P = .06),OBTCM图像质量改善(P < .002)。结论认为OBTCM对女性乳腺的潜在获益因减低管电流区域有限而被高估,尽管乳腺剂量降低9%,后部器官吸收辐射最多增加26%,未减少辐射诱发的恶性肿瘤。
要点
- 无女性全部乳腺组织位于减低管电流区域内,OBTCM对乳腺的剂量获益有限。
- OBTCM使甲状腺剂量降低18%、乳腺降低9%,但肺、肝、肾剂量分别升高17%、11%、26%。
- 常规扫描与OBTCM的癌症发病LAR无显著差异(P = .06),OBTCM图像质量改善(P < .002)。
核心结论
- OBTCM对女性乳腺的潜在获益因减低管电流区域有限而被高估;尽管乳腺剂量降低9%,后部器官吸收辐射最多增加26%,未减少辐射诱发的恶性肿瘤。
研究设计与样本
- 回顾性研究,2015年1月至2016年12月,对50例女性患者(平均年龄53.7岁±17.5,范围20-80岁)行胸部CT蒙特卡洛模拟计算患者特异性剂量分布,并对其中17例(平均年龄43.8岁±17.1,范围20-69岁)模拟临床OBTCM扫描;比较常规CT与OBTCM的图像质量。
诊断标准与关键数值
- 甲状腺剂量降低18%,乳腺剂量降低9%;肺、肝、肾剂量分别升高17%、11%、26%;癌症发病LAR在常规扫描与OBTCM间无显著差异(P = .06);OBTCM图像质量改善(P < .002)。
临床应用与阅片要点
- 原文结论指出OBTCM对女性乳腺的潜在获益因减低管电流区域有限而被高估,后部器官吸收辐射最多增加26%,未减少辐射诱发的恶性肿瘤。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Purpose To assess the potential dose reduction to the thyroid and breasts in chest computed tomography (CT) with organ-based tube current modulation (OBTCM). Materials and Methods In this retrospective study (from January 2015 to December 2016), the location of the breasts with respect to the reduced tube current zone was determined. With Monte Carlo simulations, patient-specific dose distributions of chest CT scans were calculated for 50 female patients (mean age, 53.7 years ± 17.5; range, 20-80 years). The potential dose reduction with OBTCM was assessed. In addition, simulations of clinical OBTCM scans were made for 17 of the 50 female patients (mean age, 43.8 years ± 17.1; range, 20-69 years). Posterior organs in the field of view were analyzed and lifetime attributable risk (LAR) of cancer incidence and mortality was estimated. Image quality between standard CT and OBTCM scans was compared. Results No women had all breast tissue within the reduced tube current zone. Dose reductions of 18% in the thyroid and 9% in the breasts were observed, whereas the doses in lung, liver, and kidney were 17%, 11%, and 26% higher. Overall, the LAR for cancer incidence was not significantly different between conventional and OBTCM scanning (P = .06). Image quality improved with OBTCM (P < .002). Conclusion The potential benefit of OBTCM to the female breast in chest CT is overestimated because of a limited reduced tube current zone; despite a 9% dose reduction to the female breast, posterior organs will absorb up to 26% more radiation, resulting in no reduction in radiation-induced malignancies. © RSNA, 2018.
引用
- Franck C, Smeets P, Lapeire L, et al. Estimating the Patient-specific Dose to the Thyroid and Breasts and Overall Risk in Chest CT When Using Organ-based Tube Current Modulation. Radiology. 2018. PMID: 29584596. doi:10.1148/radiol.2018170757
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。